Lineage Cell Therapeutics Inc. — Director's Dealing 2021

Apr 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lineage Cell Therapeutics, Inc. (LCTX)
CIK: 0000876343
Period of Report: 2021-04-20

Reporting Person: Amin Dipti (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-20	Stock Option (Right to Buy)	$2.28	A	90000	Acquired	2031-04-19	Common Shares (90000)	Direct

Footnotes

F1: This option shall vest in 36 monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continuous service on the board of directors of the issuer.